Preclinical pharmacokinetic characterization of amdizalisib, a novel PI3Kδ inhibitor for the treatment of hematological malignancies.
Front Pharmacol
; 15: 1392209, 2024.
Article
in En
| MEDLINE
| ID: mdl-38948472
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Front Pharmacol
Year:
2024
Document type:
Article